EDSA · Edesa Biotech Inc. Common Shares
View on chartInsiders & Stakes
| Nijhawan Pardeep Chief Executive Officer | ▲ Buy | Grant | 905,993 Shares held | 10/5/2026 | View profile |
| Brooks Michael J President | ▲ Buy | Grant | 291,479 Shares held | 5/27/2026 | View profile |
| van der Velden Peter 10% Owner | ▼ Sell | Open Market | 150,275 Shares held | 1/10/2023 | View profile |
| Weiler Peter J. Chief Financial Officer | ▲ Buy | Grant | 129,609 Shares held | 5/27/2026 | View profile |
| Marshall Patrick Director | ▲ Buy | Grant | 71,666 Shares held | 5/27/2026 | View profile |
| Sistilli Carlo Director | ▲ Buy | Grant | 49,417 Shares held | 5/27/2026 | View profile |
| MacDonald Sean Arthur Director | ▲ Buy | Grant | 41,054 Shares held | 5/27/2026 | View profile |
| Chypyha Joan Director | ▲ Buy | Grant | 30,029 Shares held | 5/27/2026 | View profile |
| Olson Charles V Director | ▲ Buy | Grant | 30,000 Shares held | 5/27/2026 | View profile |
| Liu Da David Director | ▲ Buy | Grant | 24,501 Shares held | 5/27/2026 | View profile |
| Lemieux Stephen Chief Financial Officer | ▲ Buy | Grant | 17,400 Shares held | 8/4/2023 | View profile |
| NIFFENEGGER KATHI Chief Financial Officer | ▲ Buy | Grant | 10,715 Shares held | 11/2/2022 | View profile |
Transaction History
| Nijhawan Pardeep | ▲ Buy | Grant | 6,893 | $0 | 10/5/2026 |
| Nijhawan Pardeep | ▲ Buy | Grant | 5,714 | $0 | 9/1/2026 |
| Nijhawan Pardeep | ▲ Buy | Grant | 5,324 | $0 | 8/3/2026 |
| Nijhawan Pardeep | ▲ Buy | Grant | 3,378 | $0 | 7/2/2026 |
| Nijhawan Pardeep | ▲ Buy | Grant | 153,550 | $800K | 6/16/2026 |
| Nijhawan Pardeep | ▲ Buy | Grant | 1,671 | $0 | 6/1/2026 |
| Marshall Patrick | ▲ Buy | Grant | 19,000 | $0 | 5/27/2026 |
| Chypyha Joan | ▲ Buy | Grant | 19,000 | $0 | 5/27/2026 |
| Nijhawan Pardeep | ▲ Buy | Grant | 96,913 | $0 | 5/27/2026 |
| Weiler Peter J. | ▲ Buy | Grant | 64,609 | $0 | 5/27/2026 |
| MacDonald Sean Arthur | ▲ Buy | Grant | 19,000 | $0 | 5/27/2026 |
| Brooks Michael J | ▲ Buy | Grant | 64,609 | $0 | 5/27/2026 |
| Sistilli Carlo | ▲ Buy | Grant | 19,000 | $0 | 5/27/2026 |
| Olson Charles V | ▲ Buy | Grant | 19,000 | $0 | 5/27/2026 |
| Liu Da David | ▲ Buy | Grant | 19,000 | $0 | 5/27/2026 |
| Nijhawan Pardeep | ▲ Buy | Grant | 1,159 | $0 | 5/1/2026 |
| Nijhawan Pardeep | ▲ Buy | Grant | 2,578 | $0 | 4/1/2026 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 1,000 | $7K | 3/10/2026 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 10,000 | $39K | 3/5/2026 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 10,000 | $43K | 3/4/2026 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 10,000 | $36K | 3/3/2026 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 2,000 | $4K | 3/2/2026 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 1,000 | $2K | 3/2/2026 |
| Nijhawan Pardeep | ▲ Buy | Grant | 10,016 | $0 | 3/2/2026 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 30,000 | $67K | 2/27/2026 |
| Brooks Michael J | ▲ Buy | Open Market | 2,000 | $3K | 2/26/2026 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 20,571 | $32K | 2/26/2026 |
| Nijhawan Pardeep | ▲ Buy | Grant | 82,236 | $0 | 2/19/2026 |
| Nijhawan Pardeep | ▲ Buy | Grant | 11,168 | $0 | 2/2/2026 |
| Nijhawan Pardeep | ▲ Buy | Grant | 10,444 | $0 | 1/5/2026 |
| Nijhawan Pardeep | ▲ Buy | Grant | 8,766 | $0 | 12/1/2025 |
| Nijhawan Pardeep | ▲ Buy | Grant | 6,968 | $0 | 11/3/2025 |
| Nijhawan Pardeep | ▲ Buy | Grant | 5,908 | $0 | 10/2/2025 |
| Nijhawan Pardeep | ▲ Buy | Grant | 5,981 | $0 | 9/11/2025 |
| Nijhawan Pardeep | ▲ Buy | Grant | 6,802 | $0 | 8/1/2025 |
| Nijhawan Pardeep | ▲ Buy | Grant | 7,186 | $0 | 7/2/2025 |
| Nijhawan Pardeep | ▲ Buy | Grant | 7,644 | $0 | 6/2/2025 |
| Marshall Patrick | ▲ Buy | Grant | 11,000 | $0 | 5/29/2025 |
| Sistilli Carlo | ▲ Buy | Grant | 20,001 | $0 | 5/29/2025 |
| Olson Charles V | ▲ Buy | Grant | 11,000 | $0 | 5/29/2025 |
| Nijhawan Pardeep | ▲ Buy | Grant | 263,200 | $0 | 5/29/2025 |
| Chypyha Joan | ▲ Buy | Grant | 11,000 | $0 | 5/29/2025 |
| Brooks Michael J | ▲ Buy | Grant | 207,201 | $0 | 5/29/2025 |
| Weiler Peter J. | ▲ Buy | Grant | 65,000 | $0 | 5/29/2025 |
| Liu Da David | ▲ Buy | Grant | 5,501 | $0 | 5/29/2025 |
| MacDonald Sean Arthur | ▲ Buy | Grant | 20,001 | $0 | 5/29/2025 |
| Nijhawan Pardeep | ▲ Buy | Grant | 6,392 | $0 | 5/2/2025 |
| Nijhawan Pardeep | ▲ Buy | Grant | 5,784 | $0 | 4/1/2025 |
| Nijhawan Pardeep | ▲ Buy | Grant | 6,339 | $0 | 3/3/2025 |
| Sistilli Carlo | ▲ Buy | Grant | 10,416 | $20K | 2/12/2025 |
| Marshall Patrick | ▲ Buy | Grant | 41,666 | $80K | 2/12/2025 |
| Nijhawan Pardeep | ▲ Buy | Grant | 8,264 | $0 | 2/3/2025 |
| Nijhawan Pardeep | ▲ Buy | Grant | 8,476 | $0 | 1/6/2025 |
| Nijhawan Pardeep | ▲ Buy | Grant | 6,420 | $0 | 12/2/2024 |
| Nijhawan Pardeep | ▲ Buy | Grant | 4,630 | $0 | 11/12/2024 |
| Nijhawan Pardeep | ▲ Buy | Grant | 3,300 | $0 | 10/2/2024 |
| Nijhawan Pardeep | ▲ Buy | Grant | 3,055 | $0 | 9/3/2024 |
| Nijhawan Pardeep | ▲ Buy | Grant | 3,317 | $0 | 8/1/2024 |
| Nijhawan Pardeep | ▲ Buy | Grant | 4,015 | $0 | 7/2/2024 |
| Nijhawan Pardeep | ▲ Buy | Grant | 4,785 | $0 | 6/3/2024 |
| Nijhawan Pardeep | ▲ Buy | Grant | 3,083 | $0 | 5/1/2024 |
| Nijhawan Pardeep | ▲ Buy | Grant | 3,253 | $0 | 4/1/2024 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 5,000 | $20K | 3/25/2024 |
| Nijhawan Pardeep | ▲ Buy | Grant | 2,765 | $0 | 3/1/2024 |
| Nijhawan Pardeep | ▲ Buy | Grant | 2,978 | $0 | 2/1/2024 |
| Nijhawan Pardeep | ▲ Buy | Grant | 2,908 | $0 | 1/8/2024 |
| Lemieux Stephen | ▲ Buy | Grant | 17,400 | — | 8/4/2023 |
| Brooks Michael J | ▲ Buy | Grant | 93,200 | — | 8/4/2023 |
| Nijhawan Pardeep | ▲ Buy | Grant | 99,300 | — | 8/4/2023 |
| van der Velden Peter | ▼ Sell | Open Market | 139,450 | $367K | 1/10/2023 |
| van der Velden Peter | ▼ Sell | Open Market | 12,895 | $34K | 1/10/2023 |
| van der Velden Peter | ▼ Sell | Open Market | 132,845 | $354K | 1/9/2023 |
| van der Velden Peter | ▼ Sell | Open Market | 12,284 | $33K | 1/9/2023 |
| Brooks Michael J | ▲ Buy | Grant | 4,239 | $5K | 11/2/2022 |
| NIFFENEGGER KATHI | ▲ Buy | Grant | 8,888 | $10K | 11/2/2022 |
| Nijhawan Pardeep | ▲ Buy | Grant | 228,262 | $257K | 11/2/2022 |
| Nijhawan Pardeep | ▲ Buy | Grant | 228,262 | $257K | 11/2/2022 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 20,000 | $32K | 6/30/2022 |
| Brooks Michael J | ▲ Buy | Open Market | 3,000 | $4K | 6/29/2022 |
| Brooks Michael J | ▲ Buy | Open Market | 3,000 | $5K | 6/16/2022 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 5,000 | $10K | 5/27/2022 |
| Brooks Michael J | ▲ Buy | Open Market | 3,500 | $6K | 5/25/2022 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 2,000 | $4K | 5/24/2022 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 2,000 | $6K | 3/31/2022 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 2,000 | $6K | 3/30/2022 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 2,000 | $6K | 3/29/2022 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 2,000 | $8K | 3/18/2022 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 397 | $1K | 3/17/2022 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 1,603 | $5K | 3/17/2022 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 2,000 | $6K | 3/15/2022 |
| Brooks Michael J | ▲ Buy | Open Market | 1,250 | $3K | 3/14/2022 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 2,000 | $6K | 3/11/2022 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 5,000 | $15K | 3/11/2022 |
| Brooks Michael J | ▲ Buy | Open Market | 1,000 | $3K | 3/10/2022 |
| Nijhawan Pardeep | ▲ Buy | Open Market | 1,500 | $5K | 3/9/2022 |
| Brooks Michael J | ▲ Buy | Open Market | 1,250 | $4K | 3/8/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Edesa Biotech Included in After-Market Movers List
Edesa Biotech was highlighted in a recent list of healthcare stocks showing movement during Thursday's after-market session. The company trades well below its average analyst price target, with a 52-week range spanning from $0.72 to $20.32. This inclusion suggests increased attention from traders monitoring after-hours activity in the sector.
Edesa Biotech Included in After-Market Movers List. Edesa Biotech was highlighted in a recent list of healthcare stocks showing movement during Thursday's after-market session. The company trades well below its average analyst price target, with a 52-week range spanning from $0.72 to $20.32. This inclusion suggests increased attention from traders monitoring after-hours activity in the sector.